Table 2 Comparison of plasma GFAP between Aβ− and Aβ+ participants.
Aβ− | (95% CI) | Aβ+ | (95% CI) | p | pa | |
|---|---|---|---|---|---|---|
All participants | n = 63 | n = 33 | ||||
151.42 ± 58.49 | (129.66–173.18) | 240.12 ± 124.88 | (210.05–270.18) | 7E−6 | 5.76E−7 | |
SMC | n = 49 | n = 25 | ||||
152.73 ± 58.18 | (126.35–179.11) | 252.22 ± 137.75 | (215.29–289.16) | b9E−6 | 4.8E−5 | |
Non-SMC | n = 14 | n = 8 | ||||
146.83 ± 61.58 | (112.06–181.60) | 202.28 ± 63.81 | (156.28–248.27) | 0.059 | 0.020 |